Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly ...

Tulane scientists found that an FDA-approved cancer drug may help the immune system clear out damaged cells that cause lung ...

New treatment approach shows potential in reversing lung damage caused by idiopathic pulmonary fibrosis using immune-based ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Wells Fargo analyst Tiago Fauth downgraded United Therapeutics (UTHR) to Equal Weight from Overweight with a price target of $314, down from ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

At the heart of the licensing deal is CUE-501, a bispecific molecule that can selectively deplete B cells to address ...

"This opens up an entirely new direction for potential treatment of IPF," said lead author Santu Yadav, PhD, assistant professor of medicine at the Tulane University School of Medicine.